Exploring the Differential Diagnosis of Joint Complaints in Pediatric Patients with Inflammatory Bowel Disease Authors
First Online: 05 February 2011 DOI:
Cite this article as: Dotson, J., Crandall, W. & Bout-Tabaku, S. Curr Gastroenterol Rep (2011) 13: 271. doi:10.1007/s11894-011-0181-0 Abstract
About one quarter of children with inflammatory bowel disease (IBD) experience an extraintestinal manifestation, with the most common being arthritis or arthralgia. Because of the frequency of these joint complaints and their effect on quality of life, it is important to consider all possible etiologies in order to promptly evaluate, diagnose, and possibly refer to other specialists. Pediatric gastroenterologist and IBD specialists are cognizant of the extraintestinal joint manifestations, but may be less familiar with rheumatic disease and the musculoskeletal examination. We explore the differential diagnosis of joint complaints in children, with a focus on IBD-related disease and rheumatic disease.
Keywords Pediatric Inflammatory bowel disease Arthritis Arthralgia Rheumatology Differential diagnosis Evaluation Joint Extraintestinal manifestations IBD arthropathy Musculoskeletal pain Orthopedic References Papers of particular interest, published recently, have been highlighted as: •• Of major importance
Dotson JL, Hyams JS, Markowitz J, et al. Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity. J Pediatr Gastroenterol Nutr. 2010;17(1):56–61.
Jose FA, Garnett EA, Vittinghoff E, et al. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2009;15(1):63–8.
Hyams JS. Extraintestinal manifestations of inflammatory bowel disease in children. J Pediatr Gastroenterol Nutr. 1994;19(1):7–21.
Oliva-Hemker M. More than a gut reaction: extraintestinal complications of IBD. Contemp Pediatr. 1999;16:45–64.
Passo MH, Fitzgerald JF, Brandt KD. Arthritis associated with inflammatory bowel disease in children. Relationship of joint disease to activity and severity of bowel lesion. Dig Dis Sci. 1986;31(5):492–7.
Palm O, Moum B, Jahnsen J, Gran JT. The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study). Rheumatol Oxf. 2001;40(11):1256–61.
Grossman BJ, DeBenedetti CD. Extraintestinal manifestations of chronic inflammatory bowel disease in children. Proc Inst Med Chic. 1970;28(3):119.
Israel DM, Olson AD, Ilowite NT, Davidson M. Arthritis as the initial manifestation of inflammatory bowel disease in early infancy. J Pediatr Gastroenterol Nutr. 1989;9(1):123–5.
Lindsley CB, Schaller JG. Arthritis associated with inflammatory bowel disease in children. J Pediatr. 1974;84(1):16–20.
Al-Shamali MA, Kalaoui M, Patty I, et al. Ulcerative colitis in Kuwait: a review of 90 cases. Digestion. 2003;67(4):218–24.
Palm O, Bernklev T, Moum B, Gran JT. Non-inflammatory joint pain in patients with inflammatory bowel disease is prevalent and has a significant impact on health related quality of life. J Rheumatol. 2005;32(9):1755–9.
•• Brakenhoff LK, van der Heijde DM, Hommes DW, et al. The joint-gut axis in inflammatory bowel diseases. J Crohns Colitis. 2010;4(3):257–68.
This article serves as a review of various arthropathies associated with inflammatory bowel disease, including axial and peripheral arthropathies, evaluation techniques, pathophysiology, and treatment modalities
Lehman TJA. A clinician’s guide to rheumatic disease in children. New York: Oxford University Press, Inc; 2009. p. 417.
McInerny TK AH, Campbell DE, et al. American academy of pediatrics textbook of primary care. Elk Grove Village: American Academy of Pediatrics; 2009. p. 1625–36.
Perlman MH, Patzakis MJ, Kumar PJ, Holtom P. The incidence of joint involvement with adjacent osteomyelitis in pediatric patients. J Pediatr Orthop. 2000;20(1):40–3.
Taccetti G, Trapani S, Ermini M, Falcini F. Reactive arthritis triggered by Yersinia enterocolitica: a review of 18 pediatric cases. Clin Exp Rheumatol. 1994;12(6):681–4.
Krumrey-Langkammerer M, Hafner R. Evaluation of the ILAR criteria for juvenile idiopathic arthritis. J Rheumatol. 2001;28(11):2544–7.
Jaakkola E, Herzberg I, Laiho K, et al. Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis. Ann Rheum Dis. 2006;65(6):775–80.
Salvarani C, Fries W. Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease. World J Gastroenterol. 2009;15(20):2449–55.
De Vos M. Joint involvement associated with inflammatory bowel disease. Dig Dis. 2009;27(4):511–5.
Beigel F, Schnitzler F, Paul Laubender R, et al. Formation of antinuclear and double-strand DNA antibodies and frequency of lupus-like syndrome in anti-TNF-alpha antibody-treated patients with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17(1):91–8.
Colombel JF, Loftus Jr EV, Tremaine WJ, et al. The safety profile of infliximab in patients with Crohn’s disease: the Mayo clinic experience in 500 patients. Gastroenterology. 2004;126(1):19–31.
Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial. Lancet. 2002;359(9317):1541–9.
Han PD, Cohen RD. Managing immunogenic responses to infliximab: treatment implications for patients with Crohn’s disease. Drugs. 2004;64(16):1767–77.
Kugathasan S, Levy MB, Saeian K, et al. Infliximab retreatment in adults and children with Crohn’s disease: risk factors for the development of delayed severe systemic reaction. Am J Gastroenterol. 2002;97(6):1408–14.
•• Goff I, Bateman B, Myers A, Foster H. Acceptability and practicality of musculoskeletal examination in acute general pediatric assessment. J Pediatr. 2010;156(4):657–62.
This article is of particular importance because it discusses the use of pGALs in a clinical setting and highlights portions of the pGALS screening
Foster HE, Kay LJ, Friswell M, et al. Musculoskeletal screening examination (pGALS) for school-age children based on the adult GALS screen. Arthritis Rheum. 2006;55(5):709–16.
Gniewek RA, Sandbulte C, Fox PC. Comparison of antinuclear antibody testing methods by ROC analysis with reference to disease diagnosis. Clin Chem. 1997;43(10):1987–9.
Gotthardt M, Bleeker-Rovers CP, Boerman OC, Oyen WJ. Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques. J Nucl Med. 2010;51(12):1937–49.
PubMed CrossRef Copyright information
© Springer Science+Business Media, LLC 2011